ReviewJournal of translational medicine2025

ANXA2 in hepatocellular carcinoma: orchestrating tumorigenesis, progression, and therapeutic resistance toward precision targeting.

Junyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.